Literature DB >> 17956345

Conservation of DNA damage tolerance pathways from yeast to humans.

H D Ulrich1.   

Abstract

Damage tolerance mechanisms, which allow the bypass of DNA lesions during replication, are controlled in eukaryotic cells by mono- and poly-ubiquitination of the DNA polymerase cofactor PCNA (proliferating-cell nuclear antigen). In the present review, I will summarize our current knowledge of the enzymatic machinery for ubiquitination of PCNA and the way in which the modifications affect PCNA function during replication and lesion bypass in different organisms. Using the budding yeast as a reference model, I will highlight some of the species-specific differences, but also point out the common principles that emerge from the genetic and biochemical studies of damage tolerance in a range of experimental systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956345     DOI: 10.1042/BST0351334

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  15 in total

1.  The NuA4 complex promotes translesion synthesis (TLS)-mediated DNA damage tolerance.

Authors:  Margaret Renaud-Young; David C Lloyd; Kate Chatfield-Reed; Iain George; Gordon Chua; Jennifer Cobb
Journal:  Genetics       Date:  2015-02-19       Impact factor: 4.562

2.  Recognition and cleavage of related to ubiquitin 1 (Rub1) and Rub1-ubiquitin chains by components of the ubiquitin-proteasome system.

Authors:  Rajesh K Singh; Sylvia Zerath; Oded Kleifeld; Martin Scheffner; Michael H Glickman; David Fushman
Journal:  Mol Cell Proteomics       Date:  2012-10-26       Impact factor: 5.911

3.  Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate.

Authors:  Michael J Emanuele; Alberto Ciccia; Andrew E H Elia; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

Review 4.  Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation.

Authors:  Wojciech Strzalka; Alicja Ziemienowicz
Journal:  Ann Bot       Date:  2010-12-17       Impact factor: 4.357

5.  Protein-protein interaction antagonists as novel inhibitors of non-canonical polyubiquitylation.

Authors:  Johanna Scheper; Marta Guerra-Rebollo; Glòria Sanclimens; Alejandra Moure; Isabel Masip; Domingo González-Ruiz; Nuria Rubio; Bernat Crosas; Oscar Meca-Cortés; Noureddine Loukili; Vanessa Plans; Antonio Morreale; Jerónimo Blanco; Angel R Ortiz; Angel Messeguer; Timothy M Thomson
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

6.  Involvement of a chromatin remodeling complex in damage tolerance during DNA replication.

Authors:  Karina B Falbo; Constance Alabert; Yuki Katou; Su Wu; Junhong Han; Tammy Wehr; Jing Xiao; Xiangwei He; Zhiguo Zhang; Yang Shi; Katsu Shirahige; Philippe Pasero; Xuetong Shen
Journal:  Nat Struct Mol Biol       Date:  2009-10-25       Impact factor: 15.369

Review 7.  Function of the INO80 chromatin remodeling complex in DNA replication.

Authors:  Karina B Falbo; Xuetong Shen
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

8.  PCNA ubiquitination is important, but not essential for translesion DNA synthesis in mammalian cells.

Authors:  Ayal Hendel; Peter H L Krijger; Noam Diamant; Zohar Goren; Petra Langerak; Jungmin Kim; Thomas Reissner; Kyoo-young Lee; Nicholas E Geacintov; Thomas Carell; Kyungjae Myung; Satoshi Tateishi; Alan D'Andrea; Heinz Jacobs; Zvi Livneh
Journal:  PLoS Genet       Date:  2011-09-08       Impact factor: 5.917

9.  Proofreading exonuclease activity of human DNA polymerase delta and its effects on lesion-bypass DNA synthesis.

Authors:  Ruzaliya Fazlieva; Cynthia S Spittle; Darlene Morrissey; Harutoshi Hayashi; Hong Yan; Yoshihiro Matsumoto
Journal:  Nucleic Acids Res       Date:  2009-03-12       Impact factor: 16.971

10.  Role of p97/VCP (Cdc48) in genome stability.

Authors:  Bruno Vaz; Swagata Halder; Kristijan Ramadan
Journal:  Front Genet       Date:  2013-04-30       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.